Okihiro syndrome due to a point mutation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:261647OMIM:607323Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Okihiro syndrome due to a point mutation, also known as Duane-radial ray syndrome (DRRS) caused by a point mutation in the SALL4 gene, is a rare congenital disorder that affects multiple body systems. This specific subtype is distinguished from Okihiro syndrome caused by larger deletions or other mutation types in the SALL4 gene on chromosome 20q13.2. The condition is characterized by the combination of Duane anomaly (a type of eye movement disorder in which the ability to move one or both eyes outward is limited, often with retraction of the eyeball on attempted inward gaze) and radial ray malformations affecting the upper limbs. Upper limb abnormalities can range from mild thumb hypoplasia or triphalangeal thumbs to complete absence of the thumb or radius, and may also include thenar muscle weakness or forearm anomalies. Beyond the hallmark features, Okihiro syndrome can affect additional organ systems. Some patients may have sensorineural or conductive hearing loss, renal malformations (such as horseshoe kidney, renal ectopia, or vesicoureteral reflux), and congenital heart defects (including atrial or ventricular septal defects and tetralogy of Fallot). Anal anomalies, including anal stenosis or imperforate anus, have also been reported. The clinical presentation is highly variable, even within the same family, meaning that some affected individuals may have only subtle findings while others have more significant multi-organ involvement. There is currently no cure for Okihiro syndrome. Management is supportive and multidisciplinary, tailored to the specific features present in each patient. This may include surgical correction of limb anomalies (such as pollicization for absent thumbs), strabismus surgery for Duane anomaly, hearing aids or cochlear implants for hearing loss, cardiac surgery for significant heart defects, and urological or surgical management for renal or anal malformations. Regular monitoring by a team including ophthalmologists, orthopedic surgeons, cardiologists, audiologists, and nephrologists is recommended. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Okihiro syndrome due to a point mutation.

View clinical trials →

No actively recruiting trials found for Okihiro syndrome due to a point mutation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Okihiro syndrome due to a point mutation community →

No specialists are currently listed for Okihiro syndrome due to a point mutation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Okihiro syndrome due to a point mutation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Okihiro syndrome due to a point mutationForum →

No community posts yet. Be the first to share your experience with Okihiro syndrome due to a point mutation.

Start the conversation →

Latest news about Okihiro syndrome due to a point mutation

No recent news articles for Okihiro syndrome due to a point mutation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Okihiro syndrome due to a point mutation

What is Okihiro syndrome due to a point mutation?

Okihiro syndrome due to a point mutation, also known as Duane-radial ray syndrome (DRRS) caused by a point mutation in the SALL4 gene, is a rare congenital disorder that affects multiple body systems. This specific subtype is distinguished from Okihiro syndrome caused by larger deletions or other mutation types in the SALL4 gene on chromosome 20q13.2. The condition is characterized by the combination of Duane anomaly (a type of eye movement disorder in which the ability to move one or both eyes outward is limited, often with retraction of the eyeball on attempted inward gaze) and radial ray ma

How is Okihiro syndrome due to a point mutation inherited?

Okihiro syndrome due to a point mutation follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Okihiro syndrome due to a point mutation typically begin?

Typical onset of Okihiro syndrome due to a point mutation is neonatal. Age of onset can vary across affected individuals.